Does VISMODEGIB Cause Decreased appetite? 662 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 662 reports of Decreased appetite have been filed in association with VISMODEGIB (ERIVEDGE). This represents 8.1% of all adverse event reports for VISMODEGIB.
662
Reports of Decreased appetite with VISMODEGIB
8.1%
of all VISMODEGIB reports
21
Deaths
69
Hospitalizations
How Dangerous Is Decreased appetite From VISMODEGIB?
Of the 662 reports, 21 (3.2%) resulted in death, 69 (10.4%) required hospitalization, and 7 (1.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for VISMODEGIB.
What Other Side Effects Does VISMODEGIB Cause?
Muscle spasms (1,937)
Alopecia (1,330)
Ageusia (958)
Fatigue (899)
Dysgeusia (706)
Weight decreased (688)
Nausea (669)
Death (657)
Diarrhoea (446)
Constipation (361)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which VISMODEGIB Alternatives Have Lower Decreased appetite Risk?
VISMODEGIB vs VITAMIN A
VISMODEGIB vs VITAMIN B
VISMODEGIB vs VITAMIN D NOS
VISMODEGIB vs VITAMINS
VISMODEGIB vs VOCLOSPORIN